explore -WSS

explore

author：fashion 2025-10-02 18:48:03 - browse：99

The Federal Trade Commission office glows softly inside, contrasting with the darkness outside — coverage from STAT — Adobe

Over the past two decades, hundreds of hospital mergers have escaped federal antitrust scrutiny and led to both higher prices and less competition, a new study shows.

But the study’s authors, and other researchers, believe the Federal Trade Commission’s hands often are tied. The agency simply doesn’t have enough money or people to crack down on all anticompetitive hospital deals, and some state laws shield hospital mergers from federal review completely.

“The resources available are just not commensurate with what the agency needs,” said Zack Cooper, an associate professor of health policy and economics at Yale University and one of the co-authors of the study. “This isn’t a story of the FTC not knowing what to do. I actually think they really know, very clearly, what to do. It’s a lack of resources, person power, and potentially willingness to do it.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Multiple sclerosis has subtypes with different best treatments: study

hotspot

knowledge

WSS

Bird flu in dairy cattle: New measures to control spread to humans

Drug companies' payments and gifts affect physicians' prescribing

Harvard scientists, with Google, unveil the most detailed brain map ever

Organ aging and disease risk measured by new blood test

Cigna, Humana reportedly in talks to merge

Flagship Pioneering launches a new biotech in two countries

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

How one medical school became remarkably diverse

Four alarming medical procedures we’re glad history forgot

Novavax promises a turnaround & Lilly roils the obesity market

Pancreatic cancer is often deadly, but new discoveries are raising hope

At least 13 dead in Texas as scorching temps continue

Despite FDA concern, risk that CAR

In Memoriam: Notable people who died in 2023

Fetal surgery at risk from Dobbs and new abortion restrictions

Activists slam private health insurers over coverage restrictions

Pediatric cancer treatments threatened by a new FDA policy

leisure time

J&J to emphasize cancer drugs, stop much of its vaccine research

Researchers test human milk's ability to repair gut microbiome

U.K. decision on ALS drug has neurologists, advocates up in arms

Organ aging and disease risk measured by new blood test

Pancreatic cancer is often deadly, but new discoveries are raising hope

Mayo Clinic plans $5B tech

hotspot

hotspot

knowledge

explore